Revenue growth decelerated to 7.4% in Q3 2026 from 53.3% in Q4 2025 while EPS fell 1.5% year-over-year, with operating income fluctuating between $237M and $567M over the last eight quarters, suggesting limited operating leverage as the expense base scales in line with revenue.
Brown & Brown, Inc. (BRO) annual income statement — 30-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Revenue | 6.97B | 5.76B | 4.71B | 4.2B | 3.56B | 3.05B | 2.61B | 2.38B | 2.01B | 1.86B | 1.76B | 1.66B | 1.57B | 1.36B | 1.19B | 1.01B | 966.92M | 967.88M | 977.55M | 959.67M | 878M | 785.81M | 646.93M | 546.72M | 455.74M | 365.03M | 265.4M | 188.39M | 171.49M | 143.5M | 128.16M |
| Revenue Growth % | 30.81% | 22.49% | 12.05% | 17.85% | 16.92% | 16.94% | 9.28% | 18.65% | 8.22% | 5.36% | 6.39% | 5.71% | 15.64% | 14% | 18.2% | 4.04% | -0.1% | -0.99% | 1.86% | 9.3% | 11.73% | 21.47% | 18.33% | 19.96% | 24.85% | 37.54% | 40.88% | 9.86% | 19.5% | 11.97% | 20.49% |
| Medical Costs & Claims | 2.87B | 2.94B | 2.41B | 2.19B | 1.82B | 1.64B | 1.44B | 1.31B | 1.07B | 994.65M | 925.22M | 856.95M | 811.11M | 683M | 608.51M | 508.68M | 487.82M | 0 | 0 | 0 | 0 | 374.94M | 0 | 268.37M | 0 | 0 | 0 | 0 | 0 | 0 | 28.08M |
| Medical Cost Ratio % | 41.2% | 50.93% | 51.14% | 52.08% | 51% | 53.71% | 55.12% | 54.86% | 53.18% | 53.55% | 52.49% | 51.72% | 51.75% | 50.39% | 51.17% | 50.57% | 50.45% | 0% | 0% | 0% | 0% | 47.71% | 0% | 49.09% | 0% | 0% | 0% | 0% | 0% | 0% | 21.91% |
| Gross Profit | 4.1B | 2.83B | 2.3B | 2.01B | 1.75B | 1.41B | 1.17B | 1.08B | 940.94M | 862.62M | 837.57M | 800M | 756.35M | 672.5M | 580.58M | 497.29M | 479.1M | 967.88M | 977.55M | 959.67M | 878M | 407.18M | 646.93M | 278.34M | 455.74M | 365.03M | 265.4M | 188.39M | 171.49M | 143.5M | 100.08M |
| Gross Margin % | 58.8% | 49.07% | 48.86% | 47.92% | 49% | 46.29% | 44.88% | 45.14% | 46.82% | 46.45% | 47.51% | 48.28% | 48.25% | 49.61% | 48.83% | 49.43% | 49.55% | 100% | 100% | 100% | 100% | 51.82% | 100% | 50.91% | 100% | 100% | 100% | 100% | 100% | 100% | 78.09% |
| Gross Profit Growth % | - | 23.01% | 14.26% | 15.23% | 23.78% | 20.59% | 8.65% | 14.41% | 9.08% | 2.99% | 4.7% | 5.77% | 12.47% | 15.83% | 16.75% | 3.8% | -50.5% | -0.99% | 1.86% | 9.3% | 115.63% | -37.06% | 132.42% | -38.93% | 24.85% | 37.54% | 40.88% | 9.86% | 19.5% | 43.38% | 19.98% |
| Operating Expenses | 2.15B | 0 | 932M | 856M | 783M | 555.9M | 500.8M | 505.8M | 441.5M | 391.61M | 370.54M | 359.37M | 339.16M | 303.7M | 269.2M | 222.42M | 206.78M | 698.52M | 690.37M | 634.34M | 584.61M | 152.26M | 432.83M | 102.56M | 316.42M | 268.85M | 210.07M | 143.55M | -42.1M | -36.61M | 71.75M |
| OpEx / Revenue % | 30.84% | 0% | 19.81% | 20.39% | 21.98% | 18.24% | 19.22% | 21.21% | 21.97% | 21.09% | 21.02% | 21.69% | 21.64% | 22.4% | 22.64% | 22.11% | 21.39% | 72.17% | 70.62% | 66.1% | 66.58% | 19.38% | 66.9% | 18.76% | 69.43% | 73.65% | 79.15% | 76.2% | -24.55% | -25.51% | 55.98% |
| Depreciation & Amortization | 523M | 367M | 222M | 206M | 186M | 152.9M | 134.8M | 128.72M | 109.38M | 108.14M | 107.67M | 108.31M | 103.84M | 85.42M | 78.95M | 67.15M | 64.08M | 63.1M | 59.92M | 53.2M | 47.81M | 43.31M | 31.06M | 25.67M | 21.29M | 22.4M | 15.38M | 12.24M | 9.82M | 8.83M | 5.21M |
| Combined Ratio % | 72.04% | 50.93% | 70.95% | 72.47% | 72.97% | 71.95% | 74.33% | 76.07% | 75.15% | 74.64% | 73.51% | 73.41% | 73.38% | 72.79% | 73.81% | 72.68% | 71.84% | 72.17% | 70.62% | 66.1% | 66.58% | 67.09% | 66.9% | 67.85% | 69.43% | 73.65% | 79.15% | 76.2% | -24.55% | -25.51% | 77.89% |
| Operating Income | 1.95B | 2.83B | 1.37B | 1.16B | 963M | 854.7M | 668.9M | 570.77M | 499.45M | 471M | 467.03M | 440.63M | 417.18M | 368.81M | 311.38M | 274.87M | 272.32M | 269.35M | 287.19M | 325.33M | 293.4M | 258.6M | 214.1M | 175.78M | 139.32M | 96.18M | 55.33M | 44.84M | 213.59M | 180.11M | 28.33M |
| Operating Margin % | 27.96% | 49.07% | 29.05% | 27.53% | 27.03% | 28.05% | 25.67% | 23.93% | 24.85% | 25.36% | 26.49% | 26.59% | 26.62% | 27.21% | 26.19% | 27.32% | 28.16% | 27.83% | 29.38% | 33.9% | 33.42% | 32.91% | 33.1% | 32.15% | 30.57% | 26.35% | 20.85% | 23.8% | 124.55% | 125.51% | 22.11% |
| Operating Income Growth % | - | 106.88% | 18.25% | 20.04% | 12.67% | 27.78% | 17.19% | 14.28% | 6.04% | 0.85% | 5.99% | 5.62% | 13.12% | 18.44% | 13.28% | 0.94% | 1.1% | -6.21% | -11.72% | 10.88% | 13.46% | 20.78% | 21.8% | 26.17% | 44.86% | 73.83% | 23.4% | -79.01% | 18.58% | 535.68% | 7395.77% |
| EBITDA | 2.47B | 3.19B | 1.59B | 1.36B | 1.15B | 1.01B | 803.7M | 699.48M | 608.83M | 579.15M | 574.7M | 548.94M | 521.02M | 454.22M | 390.32M | 342.01M | 336.4M | 332.45M | 347.11M | 378.53M | 341.2M | 301.9M | 245.16M | 201.45M | 160.61M | 118.58M | 70.71M | 57.07M | 223.4M | 188.94M | 33.54M |
| EBITDA Margin % | 35.46% | 55.44% | 33.77% | 32.44% | 32.25% | 33.06% | 30.84% | 29.33% | 30.29% | 31.18% | 32.6% | 33.13% | 33.24% | 33.51% | 32.83% | 34% | 34.79% | 34.35% | 35.51% | 39.44% | 38.86% | 38.42% | 37.9% | 36.85% | 35.24% | 32.48% | 26.64% | 30.29% | 130.28% | 131.67% | 26.17% |
| Interest Expense | 300M | 297M | 201M | 197M | 148M | 65M | 59M | 63.66M | 40.58M | 38.32M | 39.48M | 39.25M | 28.41M | 16.44M | 16.1M | 14.13M | 14.47M | 14.6M | 14.69M | 13.8M | 13.36M | 14.47M | 7.16M | 3.62M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Operating Income | 8M | 1.21B | -137M | -187M | -61M | 26.9M | -14.2M | -18.82M | -3.6M | -17.03M | 4.05M | -1.17M | 49.03M | -5.24M | -9.53M | -9.79M | -8.25M | 0 | 0 | 0 | 0 | 0 | 0 | -4.33M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pretax Income | 1.56B | 1.37B | 1.3B | 1.15B | 876M | 762.8M | 624.1M | 525.93M | 462.46M | 449.72M | 423.5M | 402.56M | 339.75M | 357.61M | 304.81M | 270.52M | 266.1M | 254.75M | 272.5M | 311.53M | 280.04M | 244.13M | 206.95M | 176.48M | 134.66M | 90.48M | 54.06M | 44.01M | 38.6M | 30.98M | 27.36M |
| Pretax Margin % | 22.34% | 23.79% | 27.69% | 27.29% | 24.59% | 25.03% | 23.95% | 22.05% | 23.01% | 24.21% | 24.02% | 24.3% | 21.68% | 26.38% | 25.63% | 26.89% | 27.52% | 26.32% | 27.88% | 32.46% | 31.9% | 31.07% | 31.99% | 32.28% | 29.55% | 24.79% | 20.37% | 23.36% | 22.51% | 21.59% | 21.35% |
| Income Tax | 333M | 304M | 301M | 275.6M | 204.3M | 175.7M | 143.6M | 127.42M | 118.21M | 50.09M | 166.01M | 159.24M | 132.85M | 140.5M | 120.77M | 106.53M | 104.35M | 101.46M | 106.37M | 120.57M | 107.69M | 93.58M | 78.11M | 66.16M | 49.27M | 34.83M | 20.15M | 17.04M | 15.04M | 12M | 10.6M |
| Effective Tax Rate % | 21.39% | 22.17% | 23.1% | 24.05% | 23.32% | 23.03% | 23.01% | 24.23% | 25.56% | 11.14% | 39.2% | 39.56% | 39.1% | 39.29% | 39.62% | 39.38% | 39.21% | 39.83% | 39.04% | 38.7% | 38.46% | 38.33% | 37.74% | 37.49% | 36.59% | 38.5% | 37.26% | 38.71% | 38.96% | 38.72% | 38.72% |
| Net Income | 1.22B | 1.05B | 993M | 870.5M | 671.8M | 587.1M | 480.5M | 398.51M | 344.25M | 399.63M | 257.49M | 243.32M | 206.9M | 217.11M | 184.04M | 164M | 161.75M | 153.29M | 166.12M | 190.96M | 172.35M | 150.55M | 128.84M | 110.32M | 83.12M | 53.91M | 32.79M | 26.79M | 23.56M | 18.99M | 16.77M |
| Net Margin % | 17.47% | 18.29% | 21.11% | 20.73% | 18.85% | 19.26% | 18.44% | 16.71% | 17.13% | 21.52% | 14.61% | 14.68% | 13.2% | 16.02% | 15.48% | 16.3% | 16.73% | 15.84% | 16.99% | 19.9% | 19.63% | 19.16% | 19.92% | 20.18% | 18.24% | 14.77% | 12.36% | 14.22% | 13.74% | 13.23% | 13.08% |
| Net Income Growth % | 21.92% | 6.14% | 14.07% | 29.58% | 14.43% | 22.19% | 20.57% | 15.76% | -13.86% | 55.2% | 5.82% | 17.6% | -4.71% | 17.97% | 12.23% | 1.39% | 5.52% | -7.72% | -13.01% | 10.8% | 14.48% | 16.85% | 16.79% | 32.72% | 54.18% | 64.4% | 22.41% | 13.7% | 24.09% | 13.25% | 13.3% |
| EPS (Diluted) | 3.69 | 3.16 | 3.46 | 3.05 | 2.37 | 2.07 | 1.69 | 1.40 | 1.22 | 1.41 | 0.91 | 0.85 | 0.71 | 0.74 | 0.63 | 0.56 | 0.56 | 0.54 | 0.59 | 0.68 | 0.61 | 0.54 | 0.47 | 0.40 | 0.31 | 0.21 | 0.07 | 0.12 | 0.05 | 0.06 | 0.01 |
| EPS Growth % | 0.9% | -8.67% | 13.44% | 28.69% | 14.49% | 22.49% | 20.71% | 14.75% | -13.48% | 54.95% | 7.06% | 19.72% | -4.05% | 17.46% | 12.5% | 0% | 3.7% | -8.47% | -13.24% | 11.48% | 12.96% | 14.89% | 17.5% | 29.03% | 47.62% | 216.74% | -44.75% | 131.21% | -10.36% | 366.94% | 13.76% |
| EPS (Basic) | - | 3.40 | 3.48 | 3.07 | 2.38 | 2.08 | 1.70 | 1.42 | 1.24 | 1.43 | 0.92 | 0.86 | 0.72 | 0.75 | 0.64 | 0.57 | 0.57 | 0.54 | 0.59 | 0.68 | 0.62 | 0.55 | 0.47 | 0.41 | 0.31 | 0.22 | 0.07 | 0.08 | 0.05 | 0.06 | 0.01 |
| Diluted Shares Outstanding | 330M | 313M | 284M | 280.8M | 278.6M | 277.41M | 275.87M | 274.62M | 282.21M | 277.59M | 275.61M | 280.22M | 285.78M | 285.25M | 284.02M | 280.53M | 278.64M | 275.01M | 283.12M | 272.71M | 282.04M | 279.55M | 277.78M | 275.59M | 272.17M | 252.89M | 494.61M | 338.97M | 454.08M | 327.34M | 135.51M |
Quick answers to the most common questions about buying BRO stock.
For fiscal year 2025, Brown & Brown, Inc. (BRO) reported total revenue of $5.76B. This represents a 4396.7% increase compared to $128.2M in 1996.
Brown & Brown, Inc. (BRO) is profitable, generating $1.05B in net income for the fiscal year ending 2025 with a net profit margin of 18.3%.
Brown & Brown, Inc. (BRO) reported an operating income of $2.83B, resulting in an operating profit margin of 49.1%. This margin reflects the operational efficiency of the business before interest and taxes.
Brown & Brown, Inc. (BRO) generated $2.83B in gross profit for the year, representing a gross profit margin of 49.1%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Hard-market premium gains decelerating
Metrics are mathematically derived from official filings.
Hard-Market Tailwind Losing Altitude
Revenue growth peaked at 53.3% in Q4 2025 before cooling to single digits at 7.4% in Q3 2026, a pattern consistent with commission growth catching up to prior premium rate increases as the hard pricing cycle matures across commercial property and casualty lines.
Brown & Brown's top line benefited disproportionately from the hard market's commission uplift through late 2025, with year-over-year revenue gains of 34% to 53% reflecting both rate-driven premium inflation and the GRP acquisition's contribution. The deceleration to 7.4% growth in the latest quarter appears to mark a return toward a more normalized organic cadence, and investors should treat the Q3 2026 figure as a more reliable run-rate anchor than the inflated prior quarters. Whether retention holds as carriers soften rates will be the key test of the Retail segment's pricing power, since brokerage revenue is a derived function of premium volumes that management cannot directly control.
Earnings Growth Decoupled From Revenue
Despite robust revenue growth, diluted EPS contracted year-over-year in four of the last six quarters, including a 19.2% decline in Q4 2025 and a 1.5% decline in Q3 2026, per Brown & Brown's quarterly filings, signaling that cost absorption and amortization from acquisition activity are outpacing commission gains.
Net income of $240 million in Q3 2026 on $1.7 billion of revenue implies a net margin near 14%, which is respectable for the broker group but trails the 16.6% to 21.5% range reported by Marsh McLennan and Aon. The divergence between accelerating revenue and negative EPS growth suggests that contingent consideration remeasurements, intangible amortization from the tuck-in acquisition strategy, and wage inflation for producers are absorbing incremental commission dollars before they reach the bottom line. Investors should monitor whether adjusted cash earnings (adjusted EBITDAC ex-amortization) continue to compound, because GAAP EPS here may understate underlying unit economics while simultaneously flagging genuine integration cost pressure.
Expense Ratio Leverage Under Test
Operating income fluctuated between $237 million and $567 million across the last eight quarters without a clear upward trend, indicating that Brown & Brown's expense base has scaled roughly in line with revenue rather than demonstrating meaningful operating leverage at the current growth rate.
The Q3 2026 operating income reading of zero in the reported data is anomalous relative to a trailing pattern of $337–567 million per quarter and should be treated as a data availability gap rather than evidence of an operating loss; analysts should verify the underlying figure before drawing conclusions. Where operating income is readable, the absence of a clear upward trajectory despite 30%+ revenue growth suggests compensation and acquisition-related costs are rising in parallel with the top line, a risk management has flagged implicitly through commentary on talent retention. For a broker whose largest input is human capital, the sustainability of margin expansion in a wage-inflationary environment is a more binding constraint than any underwriting cycle.
Q4 2025 Marks the Cycle Turn
Q4 2025 stands out as the inflection quarter: revenue growth hit a cyclical high of 53.3% while EPS fell 19.2% and the loss ratio compressed to 16.2% versus a normalized ~50% level, a combination that appears to reflect large acquisition-related charges coinciding with peak organic premium tailwinds.
The unusually low 16.2% loss ratio in Q4 2025 is almost certainly a revenue-mix or seasonality artifact within the National Programs segment rather than an underwriting event, given that broker loss ratios reflect pass-through premium structures rather than retained risk. More significant is the simultaneous 19.2% EPS decline against the strongest revenue print in the series, which suggests the quarter's earnings were burdened by non-recurring items — plausibly contingent consideration or GRP integration amortization — rather than operating deterioration. This quarter should be treated as a boundary marker: pre-Q4 2025 figures reflect a smaller, more US-concentrated platform, and post-Q4 comparability to prior periods is limited by the step-change in scale.
Hard-Market Revenue May Be Less Durable Than It Looks
The counter-case to Brown & Brown's reported momentum is that its revenue growth substantially lags Ryan Specialty's 21.3% and Arthur J. Gallagher's 20.7% on a like-for-like basis while its P/E multiple remains elevated, implying the valuation may already discount more hard-market carryover than the latest 7.4% growth print can support.
As a commission-based intermediary, Brown & Brown's revenue is a derivative of carrier premium rates, and the Q3 2026 deceleration to 7.4% from 34% two quarters earlier may signal that the favorable pricing cycle has largely been captured, leaving the burden of proof on acquisitions to fill the growth gap. The context flag of a significant EPS miss in a recent quarter, combined with the trailing pattern of negative EPS growth in four of six periods, could indicate that integration costs from international expansion are running structurally higher than consensus embedded, though this warrants verification against the next reported quarter. If UK and Ireland operations carry permanently higher expense ratios than the legacy US book, the blended margin profile may ratchet down even as headline revenue continues to grow, which would challenge the premise that the current multiple is justified by superior organic compounding.
Fiduciary Interest Tailwind Unquantified
Investment income is not separately reported in the supplied quarterly data, so the contribution of fiduciary interest — earned on premiums held in trust before remittance to carriers — cannot be isolated from the reported earnings stream despite being a known tailwind in the current elevated-rate environment.
For an intermediary holding substantial fiduciary funds, rising short-rate yields historically have provided a high-margin earnings boost that flows almost entirely to the bottom line, since incremental interest requires no corresponding commission expense. The absence of a discrete investment income line in this dataset means any assessment of earnings quality should assume reported net income may be partially supported by rate-sensitive interest that would compress if short rates fall, and investors should seek disclosure of fiduciary interest in subsequent filings to size this exposure. This is not a criticism of reported results, but rather a caution that the current net margin environment may include a cyclical component that is not recurring in a flat or declining rate scenario.